Merck & Co Inc [MRK] stock prices are up 0.58% to $85.20 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MRK shares have gain 8.20% over the last week, with a monthly amount drifted -5.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on April 22, 2025, when Cantor Fitzgerald initiated its Neutral rating and assigned the stock a price target of $85. Previously, Deutsche Bank downgraded its rating to Hold on February 18, 2025, and dropped its price target to $105. On February 10, 2025, downgrade downgraded it’s rating to Hold and revised its price target to $100 on the stock. Truist downgraded its rating to a Hold but stick to its price target of $110 on January 08, 2025. BMO Capital Markets downgraded its rating to a Market Perform and reduced its price target to $105 on December 20, 2024. In a note dated December 04, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $130.
The stock price of Merck & Co Inc [MRK] has been fluctuating between $75.93 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $111.5 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $85.20 at the most recent close of the market. An investor can expect a potential return of 30.87% based on the average MRK price forecast.
Analyzing the MRK fundamentals
The Merck & Co Inc [NYSE:MRK] reported sales of 63.69B for trailing twelve months, representing a drop of -1.77%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.35%, Pretax Profit Margin comes in at 0.31%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.39 and Total Capital is 0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 84.05 points at the first support level, and at 82.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.09, and for the 2nd resistance point, it is at 86.98.
Ratios To Look Out For
It’s worth pointing out that Merck & Co Inc [NYSE:MRK]’s Current Ratio is 1.36. As well, the Quick Ratio is 1.15, while the Cash Ratio is 0.47. Considering the valuation of this stock, the price to sales ratio is 3.37, the price to book ratio is 4.65 and price to earnings (TTM) ratio is 12.40.
Transactions by insiders
Recent insider trading involved Smart Dalton E. III, SVP Fin. – Global Controller, that happened on Apr 25 ’25 when 4262.0 shares were sold. Officer, DALTON SMART completed a deal on Apr 25 ’25 to buy 4262.0 shares. Meanwhile, President, U.S. Market Oosthuizen Johannes Jacobus sold 8500.0 shares on Feb 19 ’25.
